HIV integrase inhibitors as therapeutic agents in AIDS.

Abstract

HIV-1 integrase is a protein of Mr 32 000 encoded at the 3'-end of the pol gene. Integration of HIV DNA into the host cell chromosomal DNA apparently occurs by a carefully defined sequence of DNA tailoring (3'-processing (3'P)) and coupling (integration) reactions. Integration of HIV DNA into human DNA represents the biochemical completion of the invasion of the human cell (e.g., T-cell) by HIV. Unlike major successes seen in the development of clinically approved anti-HIV agents against HIV reverse transcriptase and HIV protease, there are no FDA-approved anti-HIV drugs in clinical use where the mechanism of action is inhibition of HIV integrase. This review summarises some key advances in the area of integrase inhibitors with the major focus being on new generation inhibitors. Special emphasis is placed on diketo acids with aromatic and heteroaromatic moieties, diketo acids with nucleobase scaffolds, bis-diketo acids, functionalised naphthyridines and other isosteres of diketo acids. Data pertaining to integrase inhibition and in vitro anti-HIV activity are discussed. Mention is made of drugs in clinical trials, both past (S-1360, L-870,810 and L-870,812 and present (GS-9137 and MK-0518). Other promising drugs, including those from the authors' laboratory, are referred. Resistant mutants arising from key integrase inhibitors and cross-resistance are indicated.

• Authors: Vasu Nair, Guochen Chi
• Journal: Reviews in medical virology (Rev Med Virol) 2007 Jul-Aug Vol. 17 Issue 4 Pg. 277-95 ISSN: 1052-9276 [Print] England
• PMID: 17503547 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)

Chemical References

• HIV Integrase Inhibitors
• HIV Integrase

Topics

• Acquired Immunodeficiency Syndrome (drug therapy)
• Drug Design
• Drug Resistance, Viral
• HIV (drug effects)
• HIV Integrase (genetics, metabolism)
• HIV Integrase Inhibitors (chemistry, metabolism, pharmacology, therapeutic use)
• Humans
• Structure-Activity Relationship